Human Heredity and Health in Africa (H3Africa): Global Health Bioinformatics Research Training Program (U2R)

The summary for the Human Heredity and Health in Africa (H3Africa): Global Health Bioinformatics Research Training Program (U2R) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Human Heredity and Health in Africa (H3Africa): Global Health Bioinformatics Research Training Program (U2R): This NIH Funding Opportunity Announcement (FOA), supported by funds from the NIH Common Fund (Common Fund), invites applications to support bioinformatics research training programs at low or middle income (LMIC) African country institutions with significant genomics research capacity. African applicants may propose graduate degree and long term postdoctoral bioinformatics research training in collaboration with other African or high income country (HIC) collaborators. It is expected that these training programs will address the need for bioinformatics research expertise in the H3Africa Consortium and result in sustainable centers of bioinformatics research training relevant to global health research for the African continent.
Federal Grant Title: Human Heredity and Health in Africa (H3Africa): Global Health Bioinformatics Research Training Program (U2R)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-16-012
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.310
CFDA Descriptions: Information not provided
Current Application Deadline: November 15th, 2016
Original Application Deadline: November 15th, 2016
Posted Date: August 9th, 2016
Creation Date: August 9th, 2016
Archive Date: December 16th, 2016
Total Program Funding:
Maximum Federal Grant Award: $250,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: August 9th, 2016
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-16-012.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com